Katena

Gabapentin, the active ingredient in Katena, is a gabapentinoid presented as an oral tablet for oral use. It is employed as an adjunctive therapy for epilepsy and for the management of neuropathic pain conditions such as post‑herpetic neuralgia and restless‑legs syndrome.

GNH USA supplies Katena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for each shipment. Customers benefit from reliable lead times and comprehensive after‑sales support across all regions.

Gabapentin is used to treat several neurological and pain‑related conditions.

Epilepsy (adjunctive therapy): Reduces seizure frequency when added to existing antiepileptic regimens. Neuropathic pain: Alleviates pain associated with diabetic peripheral neuropathy and other nerve‑damage conditions. Postherpetic neuralgia: Decreases chronic pain following shingles infection. Restless legs syndrome: Improves uncomfortable sensations and urges to move the legs.

Gabapentin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the lower extremities. - Nausea: mild stomach upset.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, anxiety, or suicidal thoughts. - Respiratory depression: slowed breathing, especially when combined with depressants.

When prescribing gabapentin, clinicians should consider several safety and handling measures.

Renal impairment: adjust dose based on creatinine clearance. Concomitant CNS depressants: monitor for enhanced sedation. Pregnancy: use only if potential benefit outweighs risk, as safety data are limited. Elderly patients: start at low dose and titrate slowly due to increased sensitivity. Suicidality: observe for new or worsening depressive symptoms. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Gabapentin can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce gabapentin absorption; separate dosing by at least 2 hours. - Opioids: combined use may increase risk of respiratory depression and profound sedation.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, barbiturates): may enhance sedative effects; monitor level of consciousness. - Diuretics: may increase risk of peripheral edema; observe for swelling. - Anticonvulsants (carbamazepine, phenytoin): may lower gabapentin plasma concentrations; consider dose adjustment.